Comparison Between Oral Gabapentin Versus Diclofenac Sodium in Post-operative Analgesia Laparoscopic Cholecystectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-14

Study Completion Date

2026-01-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

this study amis to compare between perioperative oral Gabapentin versus Diclofenac sodium on postoperative analgesia patients undergoing laparoscopic cholecystectomy

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Optimizing Pain Management Following Laparoscopic Cholecystectomy RCT

NCT05214157

Acute Post-operative Pain Cholecystectomy, Laparoscopic Pain Assessment Pain Intensity +1 more

COMPLETED NA

Duloxetine for Postoperative Pain of Laparoscopic Cholecystectomy

NCT05115123

Pain, Postoperative

COMPLETED PHASE2

Use of Preoperative Gabapentin in Patients Undergoing Laparoscopic Cholecystectomy

NCT03583892

Pain, Postoperative

UNKNOWN

Relationship Between Acute Phase Markers and Post-operative Pain in Laparoscopic Cholecystectomy: An Observational Study

NCT06375057

Post Operative Pain

RECRUITING

Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy

NCT00209885

Cholecystolithiasis

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholecystitis, Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A will receive oral Gabapentin

Patients included in this group will receive 600 mg of gabapentin 2 h before surgery.

Group Type ACTIVE_COMPARATOR

Gabapentin

Intervention Type DRUG

oral Gabapentin will be given 2 hours perioperative as postoperative analgesia patients undergoing laparoscopic cholecystectomy

group B will receive diclofenac sodium

Patients included in this group will receive 100 mg diclofenac sodium 2 h before surgery.

Group Type ACTIVE_COMPARATOR

Diclofenac Sodium

Intervention Type DRUG

oral diclofenac sodium will be given 2 hours perioperative as postoperative analgesia patients undergoing laparoscopic cholecystectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gabapentin

oral Gabapentin will be given 2 hours perioperative as postoperative analgesia patients undergoing laparoscopic cholecystectomy

Intervention Type DRUG

Diclofenac Sodium

oral diclofenac sodium will be given 2 hours perioperative as postoperative analgesia patients undergoing laparoscopic cholecystectomy

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Age from 20 to 60 years old. Both sexes. American Society of Anesthesiologists (ASA) physical status I- II. Patients undergoing laparoscopic cholecystectomy.